Biomarkers US 2024

28 - 29 October 2024 | San Diego, CA

Ensuring robust biomarker validation & identification to improve clinical outcomes, enable better diagnosis & facilitate precision medicine

Explore Biomarkers US 2024: Addressing Challenges Across The Biomarkers Discovery & Development Landscape

Explore the latest developments in the biomarker field through the 8th Annual Biomarker & Precision Medicine US Congress, which brings together experts from global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions all focussed on emerging tools and strategies within translational science, diagnostics and biomarker development. 

8th Annual Biomarker & Precision Medicine US Congress

  • Enable effective biomarker identification and characterization across multiple disease areas, including neuroscience, oncology & rare disease, to accelerate novel drug candidates to commercially successful products
  • Integrate multi-omic technologies into your workflows to drive the development of precision medicines, with discussion of spatial technologies, single cell analysis and AI-driven imaging
  • Gain novel insights into next-generation diagnostic tools in order to improve clinical outcomes. Further talks look at the implementation of companion diagnostics in drug development to enable therapeutic success

Agenda at a Glance


  • Day One | Track 1: Novel Biomarker Discovery, Identification & Characterization 
  • Day One | Track 2: Effective Clinical Biomarker Strategies
  • Day One | Track 3: Multi-Omics For Precision Medicine
  • Day Two | Track 1: Emerging Strategies For Biomarker Validation & Data Analysis
  • Day Two | Track 2: High-Quality Biospecimens in Clinical Development & Precision Medicine
  • Day Two | Track 3: Innovative Tools & Technologies For Next-Gen Diagnostics

What to Expect

430

leading pharma, biotech, & academic delegates

35
hours of presentations, discussions & interactive content
11
hours of networking breaks, including speed networking & refreshments
57
hours of pre-arranged 1-2-1 meetings, facilitating business growth
Interactive Presentations
Exhibition Hall
Networking Drinks
Poster Display
Event App Swapcard

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of experiences

  • Engaging Thought Leadership

    Over 60 dynamic interactive discussions, roundtables, and presentations curated with insights from top industry leaders and experts
  • Global Technological Showcase

    An international exhibition showcasing cutting-edge technologies and services from leading providers in the scientific field.
  • Networking Emphasis

    Unparalleled networking opportunities, including speed networking sessions, a vibrant drinks reception, and informal gatherings to foster meaningful connections
  • Innovative Poster Displays

    Inspiring poster displays and presentations unveiling the latest breakthroughs from emerging biotech, pharma, and academic institutions

Key Themes for Biomarkers US 2024

The 2024 programme will delve into the intricacies of navigating regulatory barriers in clinical trials, with a specific focus on companion diagnostics (CdX) and the complexities of biomarkers. Discussions will also revolve around the pivotal role of biomarkers in clinical development, exploring advancements in spatial tissue imaging and the integration of AI technologies in biomarker research. With precision medicine also at the forefront, key opinion leaders will examine how these innovations are shaping the landscape of healthcare and the future of personalized treatment approaches within clinical trials. 

Companies Represented Include

Meet Our Expert Speakers

Biomarkers US 2024 again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative, data and industry outlooks.

Below are some of our featured speakers:

Anand Giddabasa
Head of Global Science and Technology, Comparative Medicine,
Pfizer
Arpita Ray
Principal Scientist,
Genentech - South San Francisco, CA
Heather Cohen
Senior Director,
Bicycle Therapeutics
Jean-Francois Martini
Executive Director, BCAT Group Head,
Pfizer Inc
Kristie Grebe
Senior Director of Clinical and Translational Development Clinical Development Lead for Celiac and MS programs,
Anokion
Kristina McGuire
Senior Director, Precision Medicine,
Regeneron
Kyuho Han
Chief Executive Officer,
MEDiC Life Sciences
Lokesh Agrawal
Dir,
NCI
Robert Getzenberg
Medical Director Diagnostics, Oncology,
Astellas
SATYA SAXENA
Director, Global Proteomics,
Eisai, Inc
William Weber
Associate Scientific Director-Pathology-SME,
Takeda
Yang Li
Principal Scientist,
Ionis Pharmaceuticals
Anmarie Boutrin
Medical Devices Regulatory Scientist – Regulatory CMC & Devices,
UCB
David Weingeist
Scientific Director, Oncology Precision Medicine & Diagnostics,
Janssen Pharmaceutical Companies of Johnson & Johnson
Jadwiga Bienkowska
Senior Director, Computational Biology ORD,
Pfizer Ltd
Katie Newhall
VP Translational,
Cellectis
KC Hart
Senior Scientist,
IGM Biosciences
Minghao Song
Director, Precision Medicine Lead,
AstraZeneca
Simon Filosto
Director, Cell Biology, Translational Medicine,
Kite Pharma
Sripad Ram
Digital Pathology and Image Analysis Lead,
Pfizer Inc

Interested in Sponsoring?

Oxford Global’s range of sponsorship opportunities are highly effective in enabling market immersion and visibility, with direct access to clients and potential customers.

Learn more

Latest Resources

Life Science Players Join €23m European Project for Precision Medicine, PRECISEU

The project will bring together life science institutions across European nations in the interest of expanding development of and access to advanced therapy medicinal products.

Feinstein Institutes Links Blood Biomarkers to Psychosis in Alzheimer's Patients

The global aging population means that rates of Alzheimer's disease are expected to reach 14 million patients by 2060, many of whom will experience psychosis.

ZERO Precision Medicine Programme Reports Outstanding Efficacy in High-Risk Paediatric Cancers

The first-of-its-kind trial presents a positive outlook for cancer types with historically poor survival rates.

Hope for New Prognostic Biomarkers & Therapeutic Options From Tumour Metabolism-Targeting Breast Cancer Study

Understanding the interplay between the tumour microenvironment and immunometabolic states could unlock a wealth of therapeutic targets and biomarkers.

New Zika-Specific Synthetic Biomarker Can Differentiate From Dengue Virus

A test that identifies Zika distinct from dengue could make a definite impact to expectant mothers and reproductive-age women that are at risk from the mosquito-borne disease.

Blood Test for Alzheimer's Granted Breakthrough Device Status by FDA

A blood test for the phosphorylated protein pTau-217 could be a critical step towards early diagnosis and screening of Alzheimer's disease.

Plan Your Visit

DoubleTree by Hilton Hotel San Diego - Mission Valley
7450 Hazard Center Dr, San Diego, CA 92108

By Trolley

The closest Trolley stop to the hotel is Hazard Center Station – this stop is served by the Sycuan Green Line. The hotel is a 7 mins walk from the station. When alighting at this stop, walk north on Hazard Center East Driveway towards Hazard Center Drive. Then turn left and the hotel will be on your right.

By Car

There is self-parking available (garage parking) at the hotel for $34 (this may be subject to state local taxes). There is no valet parking at this venue. For further information please contact the hotel directly. For driving instructions and a map, please click here

By Air

San Diego International Airport – The DoubleTree by Hilton San Diego – Mission Valley is 7 miles from the International Airport. A single taxi ride to the hotel will cost approx. $40 and will take around 20 minutes. Transportation to/from the hotel is provided by Super Shuttle, Cloud 9, or other shuttle services for approx. $10-$15 per person. Please click here for more information on travelling to the hotel from the airport.

By Bus

The closest bus stop to the venue is Camino De La Reina & Mission Center Rd, which is a 13min walk away. When alighting at this stop, walk north on Mission Center Rd towards Camino De La Reina. Turn left onto Hazard Center Dr and then right on to Frazee Rd – the hotel should be on the right hand side. Please click here for more information on Trolley and bus services in the area.

Oxford Global has secured a number of bedrooms at the DoubleTree by Hilton Hotel San Diego - Mission Valley at a reduced conference rate: 

 

  • Sunday 27th October 2024 – $265 (includes room rate, taxes & daily continental breakfast)
  • Monday 28th October 2024 – $265 (includes room rate, taxes & daily continental breakfast)

Should you wish to book a room, please email help@oxfordglobal.com. The final cut-off date to book bedrooms is Friday 27th September 2024 – any bookings after this date are subject to availability and rates - any cancellations after 4th October are subject to full cancellation charges.

 

Additionally, we kindly remind all attendees to only book their accommodation if they are registered for the event. This ensures that accommodations are available for those who have officially secured their attendance.

We are closely monitoring the official guidance from health authorities, local governments, and the World Health Organization in order to support the health and well-being of our global community. The health and safety of our staff, customers and clients remains our number one priority.

As we continue to move forward with hosting our events in-person in 2024, we’ve added a series of Health & Safety guidelines and precautions in order to prepare for event safety. We carry out risk assessments for all our events to evaluate fundamental considerations and how to cover multiple risk scenarios.

Oxford Global has learned that third-party companies (recently EHotel Services, Business Travel Management/btravelmanagement and Exhibitors Hotel Reservations Services) are targeting conference attendees with a fraudulent hotel booking scheme.

Please note that none of these third-party companies are associated with Oxford Global in any way, nor have Oxford Global authorised them to use their names or trademarks on information they send out to attendees.

If you are contacted by a third-party company by phone or email using Oxford Global’s name or the name of Biomarkers US 2024 and offering accommodation services, we urge exhibitors and attendees to proceed with extreme caution before signing anything sent by these companies or entering into any conversation or replying to any emails sent from these third-party companies.

Register Your Interest

Submit your details and a member of our team will be in touch